Actionable Stock Market Trading Newswire. Built for Traders, by Traders.
All news is property of their respective owners.

Karuna Therapeutics Q3 EPS $(2.38) Down From $(1.72) YoY

Karuna Therapeutics (NASDAQ:KRTX) reported quarterly losses of $(2.38) per share. This is a 38.37 percent decrease over losses of $(1.72) per share from the same period last year.

byBenzinga Newsdesk

November 3, 2022

1 minute read

Karuna Therapeutics (NASDAQ:KRTX) reported quarterly losses of $(2.38) per share. This is a 38.37 percent decrease over losses of $(1.72) per share from the same period last year.

‘Palantir may lose a lucrative contract for ICE’s tool that targets unauthorized workers, according to a government document’ -Business Insider Report

By Benzinga Newsdesk

Today, 4:24 PM

https://www.businessinsider.com/palantir-may-lose-lucrative-ice-contract-falcon-raven-2021-9

PLTR

Kevin O’Leary Says Bitcoin Won’t Break Above $25,000 Until This Happens

By Bibhu Pattnaik

Today, 4:24 PM

O'Shares ETFs chairman and renowned Shark Tank investor Kevin O'Leary has once again spoken about Bitcoin (CRYPTO: BTC) and the sustainability of holding the apex crypto.

BTC

Tantech Reports Offering Of Shares Via Aegis Capital, No Size/Terms Disclosed

By Benzinga Newsdesk

Today, 4:24 PM

Tantech Holdings Ltd (NASDAQ:TANH) ("Tantech" or the "Company") today announced that it intends to offer its common shares in an underwritten public offering. The Company intends to use the net

TANH